Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Director's Dealing 2010

Feb 12, 2010

1643_dirs_2010-02-11_b26659b6-0a39-49cb-b2af-97e88a6d9024.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CHATTEM INC (CHTT)
CIK: 0000019520
Period of Report: 2010-02-09

Reporting Person: SANOFI-AVENTIS (10% Owner)
Reporting Person: River Acquisition Corp. (10% Owner)
Reporting Person: Sanofi-Aventis Amerique du Nord S.N.C. (10% Owner)
Reporting Person: AVENTIS INC (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-09 Common Stock, without par value P 28864905 $93.50 Acquired 44622694 Indirect
2010-02-09 Common Stock, without par value P 552321 $93.50 Acquired 45175015 Indirect
2010-02-10 Common Stock, without par value P 300936 $93.50 Acquired 45475951 Indirect
2010-02-11 Common Stock, without par value P 923268 $93.50 Acquired 46399219 Indirect

Footnotes

F1: Reflects shares acquired by Aventis Inc. ("Aventis") from Chattem, Inc. ("Chattem"), pursuant to the exercise of the "top-up" option provided for in the Agreement and Plan of Merger, dated as of December 20, 2009, among sanofi-aventis ("Parent"), River Acquisition Corp. (the "Purchaser") and Chattem, and subsequently contributed to the Purchaser.

F2: The shares are held by the Purchaser. The Purchaser is an indirect, wholly-owned subsidiary of Parent and a direct, wholly-owned subsidiary of Aventis. Aventis is a wholly-owned subsidiary of Sanofi-aventis Am??rique du Nord S.N.C. ("ADN"). ADN is a wholly-owned subsidiary of Parent. The shares may also be deemed to be indirectly beneficially owned by Parent, ADN and Aventis.

F3: Reflects shares purchased in a tender offer.